TNFSF11 and major depressive disorder: In a study examining levels of bone turnover markers in medication-free inpatients with recurrent MDD, patients with MDD exhibited decreased levels of baseline OPG/RANKL and plasma OPN, indicating MDD may modulate bone physiology independent of SSRI use (Kadriu et al., 2018).